← Back to Search

Education Program to Reduce Risky Behavior in Adolescents Ph I (iTRAC Trial)

N/A

Waitlist Available

Led By Christopher D Houck, PhD

Research Sponsored by Klein Buendel, Inc.

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, after wireframe production (approximately 2 months after baseline)

Awards & highlights

No Placebo-Only Group

Summary

This phase will complete the TRAC adaptation to a web app. The pilot study (R21 HD089979) effectively translated the ER content of TRAC and the same procedures will be used to translate the remaining content.

Eligible Conditions

Risky Sexual Behavior
Emotional Regulation
Adolescent Behaviors

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, after study completion (approximately 2 months after baseline), 6-months after baseline

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, after study completion (approximately 2 months after baseline), 6-months after baseline

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, after study completion (approximately 2 months after baseline), 6-months after baseline for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Formative Research

Secondary study objectives

Abstinence Attitudes

Adolescent Risk Behavior Assessment (ARBA)

Non-sexual Risk Behaviors

+1 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups

Experimental Treatment

Group I: Health Education Professionals Panel (HEPP)Experimental Treatment1 Intervention

This panel consisted of 6 health teachers and other school health professionals such as nurses and counselors. They were recruited at each participating school.

Group II: Adolescent Advisory Board MaleExperimental Treatment1 Intervention

This board consisted of 9 male adolescents recruited from the schools.

Group III: Adolescent Advisory Board FemaleExperimental Treatment1 Intervention

This board consisted of 9 female adolescents recruited from the schools.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Formative Research- Content Translation

2022

N/A

~30